In one of our most recent videos, we made the case for why holding cash isn’t the best idea, even as the market folds like a cheap TV tray. That’s because time in the market generally beats timing the market. All the research points to investors being unable to successfully time the market. Instead, invest in quality assets over time and don’t overpay. Lump sum investing beats out dollar cost averaging marginally, so perhaps a hybrid approach gives you the best of both worlds. And if you must stock pick, only invest in quality companies as they’ll be less likely to go bust when things go south.
One quality company is Intuitive Surgical (ISRG), by far the market leader in robotic surgery, with strong recurring revenues, high gross margins, and a ton of cash on hand to help fund its continued domination. However, it’s been more than three years since we first fully profiled the company while still exploring the robotic surgery investment thesis. Robotic surgery is a technology at the intersection of robotics (of course), artificial intelligence, and the massive
Sign up to our newsletter to get more of our great research delivered straight to your inbox!
Nanalyze Weekly includes useful insights written by our team of underpaid MBAs, research on new disruptive technology stocks flying under the radar, and summaries of our recent research. Always 100% free.
Become a premium member and get access to hundreds of premium articles, reports and additional content.
Nanalyze Premium is your comprehensive guide to investing in disruptive technologies. Read by the top investment banks, management consultancies, VCs, and research houses. Trusted by over 100,000 institutional and retail investors. Covering disruptive technologies for over 18 years.